What causes seizure in focal epilepsy?
A study reveals that early activation of astroglia in focal epilepsy drives neurons to generate epileptic discharges. This neuron-astrocyte interaction may represent a novel target for controlling epilepsy.
Articles tagged with Epilepsy
A study reveals that early activation of astroglia in focal epilepsy drives neurons to generate epileptic discharges. This neuron-astrocyte interaction may represent a novel target for controlling epilepsy.
UCLA researchers have made a direct recording of mirror neurons in the human brain, showing they are more widely distributed than previously thought. The study found that specific subsets of mirror cells increased activity during action execution but decreased it when observing an action.
A national study by Queen's University researchers has found a strong correlation between Fetal Alcohol Spectrum Disorder (FASD) and a high prevalence of epilepsy. Six percent of participants had epilepsy, while twelve percent experienced one or more seizures in their lifetimes.
Children with fetal alcohol spectrum disorder (FASD) are at a high risk of developing epilepsy or seizure history, according to a new study. Researchers found that six percent of individuals with FASD developed epilepsy and 12 percent had one or more seizures in their life.
Researchers found that image recognition and memories are stronger when neurons fire in sync with local theta waves during the learning process. The study also established a direct relationship between individual neuron spike timing relative to theta oscillations and human behavior.
A recent study found that deep brain stimulation significantly reduced seizure frequency in patients with refractory partial and secondarily generalized seizures, with a 56% reduction in seizure frequency by 2 years. The benefits of stimulation persisted long-term, with improved responder rates.
A new NIH-funded clinical trial has found that ethosuximide is the most effective treatment for childhood absence epilepsy, with no intolerable side effects. The study enrolled 453 children and showed that ethosuximide and valproic acid were significantly more effective than lamotrigine in controlling seizures.
A Phase III clinical study published online in Epilepsia found that Vimpat (lacosamide) demonstrated significantly fewer partial-onset seizures versus placebo in adults living with epilepsy. The study showed that patients taking Vimpat had greater reductions in seizure frequency and a higher 50% responder rate compared to placebo.
A comprehensive clinical trial established an evidence-based approach for initial drug therapy of childhood absence epilepsy. Ethosuximide was found to provide the best combination of seizure control and fewest attentional side effects, making it a sensible choice for initial monotherapy.
Researchers found that lacosamide 400 mg/day provides good efficacy and tolerability for patients with uncontrolled partial-onset seizures, while higher doses may provide additional benefits. The study confirms the safety and effectiveness of adjunctive lacosamide treatment in reducing seizure frequency and severity.
Dolphins' health is shedding light on human and ocean health. Researchers have discovered that diseases found in dolphins are similar to human diseases, providing clues into how human health might be affected by contaminated coastal water or seafood. High levels of PCBs in dolphins may be suppressing their immune function.
Researchers at UCLA's Pediatric Epilepsy Surgery Program have found that a non-invasive approach to pre-surgical testing, combined with earlier consideration for surgery, is associated with the best seizure-free surgical outcome in patients with TSC. Approximately two-thirds of TSC patients became seizure-free after surgery.
Researchers discovered that UV LED light can reduce seizure-like activity in rat epilepsy models by releasing gamma aminobutyric acid (GABA), a natural neurotransmitter. The study suggests that this technique could be translated to human focal epilepsy, offering an alternative treatment option.
The pivotal trial data demonstrate that the RNS System significantly reduced seizure frequency among people with medically intractable partial onset epilepsy. The device delivered brief and mild electrical stimulations to suppress seizures, with a mean percentage reduction of 29% in disabling seizures.
A global consensus definition of refractory epilepsy has been developed to aid better care for patients caught in the treatment gap. The definition highlights the need for state-of-the-art care for millions of people with epilepsy worldwide, who are currently not receiving adequate treatment.
Scientists have recorded spontaneous epileptic activity in human brain tissue for the first time, revealing that electrical connections between nerve cells cause the disease. This discovery offers real hope for finding new treatments for epilepsy, which affects 45 million people worldwide.
A recent study published in Epilepsia found that current cigarette smokers are at a significant risk of seizure. The study analyzed data from over 116,000 female nurses and found that long-term moderate caffeine or alcohol use is not associated with an increased risk of seizures or epilepsy.
Researchers found a gene deletion in chromosome 15 associated with significant learning and behavioral problems, including developmental delay, mental retardation, and epilepsy. The study suggests that the nicotinic receptor plays a crucial role in these conditions.
Researchers at Baylor College of Medicine have identified a potassium channel KvLQT as the molecular trigger for sudden death in epilepsy. This discovery could lead to a simple genetic screening test to identify patients at risk, offering effective treatments such as beta blockers and cardiac pacemakers.
A Duke University researcher has discovered a receptor that receives messages from astrocytes, which can form excitatory synapses in the brain. The discovery may explain why people develop epilepsy or have neuropathic pain, and could lead to new therapies for these conditions.
Packages of care aim to improve epilepsy recognition and management, closing the 'treatment gap' in LMICs. Epilepsy affects 65 million people worldwide, with limited access to effective treatment.
Studies suggest that routine stroke prevention therapies could be highly effective in the very elderly population. Meanwhile, research on epilepsy in later life is needed to improve treatment and prognosis for this growing demographic.
Researchers at the University of Utah Health have discovered a gene mutation that causes severe epilepsy and febrile seizures in some infants. The SCN9A gene mutation can alter sodium channel function in the brain, leading to seizures, and may be responsible for up to 5% of febrile syndrome patients.
Children with microcephaly are at risk of neurologic and cognitive problems, including epilepsy, cerebral palsy, mental retardation, and eye and ear disorders. Doctors recommend screening for coexisting conditions, brain scans, and genetic testing to identify the causes of microcephaly.
Researchers found that similar symptoms occur in many systems as they approach a critical state of transition, indicating 'tipping points' for abrupt changes. These early-warning signals are observed in ecosystems, financial markets, and human physiology, highlighting the potential for catastrophic bifurcations.
A study found that 1 in 8 patients thought to have epilepsy or unsure diagnosis actually had a heart rhythm issue causing fainting. Eighty percent of those who underwent pacemaker insertion were symptom-free after 9 months.
Researchers at Beth Israel Deaconess Medical Center discovered a genetic link between childhood brain development and adult-onset epilepsy, highlighting the fragility of the brain during early childhood. The study identifies a new pathway controlling neuron circuit maturation, which may lead to new therapies for this condition.
A study published in Neurology found that children with normal IQs before a first seizure may experience language, memory, learning and other cognitive skills problems. Children who took epilepsy drugs had difficulties in processing speed, verbal memory, and learning.
A study found that women with epilepsy who experience seizures during pregnancy are more likely to give birth to pre-term and small babies than those without epilepsy. The study analyzed data from over 1,000 women with epilepsy and found a significant association between seizure activity and adverse pregnancy outcomes.
Researchers at the University of Leeds have successfully prevented epilepsy in mice by identifying a faulty gene as the cause. The study, published in PNAS, offers irrefutable proof that a defective version of the Atp1a3 gene is responsible for causing epileptic seizures in mice.
Researchers have devised a chemical technique to discover brain function and provide clues for treating brain diseases. The technique allows neuroscientists to noninvasively activate entire populations of neurons in an animal brain, promoting understanding of brain function and disease treatment.
Researchers at Baylor College of Medicine have identified a single gene mutation responsible for catastrophic epilepsy, a condition marked by severe muscle spasms, persistent seizures, and mental retardation. The discovery provides a new model for studying the disease and has sparked hope for potential treatments.
A CU-Boulder study found that chemicals released by the brain's immune system can cause chronic seizures in people who have suffered a traumatic head injury. The research suggests that temporarily shutting down the immune response could prevent the development of acquired epilepsy.
Researchers at the University of Montreal Hospital Research Centre have developed a new surgical technique to treat refractory epilepsy, with nine patients showing successful results. The innovative approach reduces risks and complications associated with previous insular surgeries.
Researchers at Rutgers University have discovered a potential new treatment for childhood epilepsy, using the therapeutic drug rapamycin to suppress epileptic seizures in mice. The study, published in Disease Models and Mechanisms, shows promise for treating cortical dysplasia, a common cause of childhood epilepsy.
Researchers developed genetically engineered mice that experience seizures resembling those in patients with infantile spasms. The discovery provides a new opportunity to test treatments that may benefit children with this difficult-to-treat form of childhood epilepsy.
A new brain-scanning process developed by University of Minnesota researcher Bin He holds promise for epilepsy treatment advancements. The technique uses functional neuroimaging to identify seizure foci and aid surgeons in pinpointing the brain network affected by seizures.
Researchers identified a new anticonvulsant compound that eliminates seizures in a model of epilepsy by inhibiting ion channels associated with the disease. The study found that blocking these channels can prevent subsequent seizures, offering a promising treatment for epilepsy.
Studies found that employees with epilepsy cost third-party payors nearly three times more on average per year compared to those without the condition. Comorbidities accounted for 80% of insurers' total annual costs for epilepsy patients.
A new study analyzed dialogue between neurologists and epilepsy patients, revealing significant gaps in communication. Discussions of mood- and behavior-related topics occurred in only 22% of visits, while 57% of patients reported issues post-visit that physicians were not aware of.
A new treatment has been discovered for restless legs syndrome (RLS) that improves sleep. Pregabalin, a commonly used epilepsy and anxiety medication, was found to be effective in reducing RLS symptoms by nearly two-thirds of participants. The study showed significant improvements in deep sleep stages compared to those taking a placebo.
New American Academy of Neurology and American Epilepsy Society guidelines suggest pregnant women with epilepsy consider avoiding valproate, a drug linked to increased fetal malformations and decreased thinking skills. The guidelines recommend regular blood testing to adjust medication doses.
A study published in the Journal of Neuroscience found that a specific gene can be 'switched on' in animals without a genetic predisposition to epilepsy, leading to changes in calcium channels and brain activity. This discovery may reveal a new mechanism for how epilepsy develops in some individuals.
Researchers at Cardiff University have identified a key molecule involved in Lithium's action on the brain. Increasing IMPase levels can lead to higher PIP3 production, which is reduced by Lithium treatment.
Researchers found that cognitive behavioral therapy can reduce the frequency of seizures in patients with PNES, improving their overall quality of life. The study also showed significant improvement in depression, anxiety, and psychosocial functioning.
A landmark study found that three-year-olds exposed to valproate during pregnancy had average IQs six to nine points lower than those exposed to other antiepileptic drugs. The study recommends women with epilepsy try alternative treatments before taking valproate.
A new study published in Epilepsia reveals that surgery for babies and toddlers suffering from epilepsy is relatively safe and effective in controlling seizures. Early surgery may also have a positive impact on brain development.
Researchers found two widely-prescribed anticonvulsants may lead to increased cholesterol, C-reactive protein and other markers of cardiovascular disease. Switching patients to newer drugs resulted in significant declines in these markers.
A study published in Epilepsia finds that individuals with epilepsy are at a higher risk of depression, with racial minorities having seven times the odds of depression compared to Caucasians. The study suggests routine screening and targeted interventions for depression are needed to help serve those with epilepsy.
Severe pediatric epilepsy is generated from within the memory-forming hippocampus, according to a study by UC San Diego researchers. The discovery could pave the way for improved treatments of childhood epilepsy, which affects over two percent of children worldwide.
A new paper suggests that four specific processes occur only in conscious perception tasks, offering a unique insight into the neural correlates of consciousness. By studying brain activity of patients with epilepsy, researchers isolated four converging electrophysiological markers characterizing conscious access after word perception.
A study of over 1.6 million young people in Denmark found that traumatic brain injury significantly increases the risk of epilepsy, with risks persisting for more than a decade after the injury. The risk is particularly high for those with severe brain injuries or family histories of epilepsy.
Researchers have identified a new gene, ELP4, linked to Rolandic epilepsy, a common form of childhood epilepsy. The discovery supports a new theory about the causes of epilepsy and offers insights into other cognitive and behavioral disorders such as ADHD, speech dyspraxia, and DCD.
A Phase III clinical study published online in Epilepsia found that Vimpat significantly reduced seizure frequency per 28 days from baseline compared to placebo. The study demonstrated efficacy in patients with uncontrolled partial-onset seizures, with higher rates of seizure reduction and complete seizure freedom among those receiving...
A new study from Tel Aviv University found that occupational stress has no effect on epilepsy attacks, with a large sample size allowing for high predictive power. The research benefits those who have been seizure-free for a long period of time, showing they are likely to stay seizure-free.
Studies show Keppra XR reduces nervous system side effects compared to levetiracetam immediate release, and a new dosing schedule may offer improved tolerability. The once-daily formulation also demonstrates bioequivalence in healthy adults.
Scientists present reports on novel technologies to restore memory circuits, alter drug effects, deliver targeted therapies and improve brain imaging. The advancements aim to pinpoint seizure causes and deliver precise treatments, promising a new era in epilepsy care.
Researchers at Rice University have identified a potential connection between glutamate and phosphoinositide 3-kinase (PI3K) in the development of neurological disorders. A mutation in a glutamate receptor gene found in both fruit flies and humans can disrupt regulatory mechanisms, leading to increased neuronal excitability.
The report proposes detailed medical history, neurological examination, and diagnostic tests as essential steps in diagnosing and treating epilepsy. The consensus also outlines the need for weight seizure control, side effects, and long-term safety when making treatment decisions.
A Mayo Clinic study found that withdrawing anti-seizure medication in children with epilepsy who have achieved seizure-freedom is generally safe and carries a low risk of developing intractable epilepsy. The study, which reviewed records of 241 children, found only 5% to develop intractable epilepsy after withdrawal.